7LagrandWK, NiessenHW, WolbinkGJ, etal. C-reactive protein colocaliaes with complement in hmnanhearts during acute myocardial infarction [ J ]. Circula-tion, 1997,95( 1 ) :97.
二级参考文献19
1Jabs WJ, Logering BA, Gerke P, et al. Kidney as a second site of human C-reactive protein formation in vivo. Eur J Immunol, 2003, 33:152 - 161.
2Shrive AK, Gheetham GM, Holden D, et al. Three dimensional structure of h uman C-reactive protein. Nature Struc Biol, 1996, 3:346 -354.
3Angrawal A, Lee S, Carson M, et al. Site-directed mutagenesis of the phosphocholine-binding site of human C-reactive protein: role of Thr76 and Trp67. J Immunol, 1997, 158:345 -350.
4Pasceri Ⅴ, Willerson JT, Yeh ET. Direct proinflammatory effect of Creactive protein on human endothelial cells. Circulation, 2000, 102:2165 -2168.
5Pasceri Ⅴ, Cheng JS, Willerson JT, et al. Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation, 2001,103:2531 -2534.
6Torzewki J, Torzewski M, Bower DE, et al. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. Arterioscler Thromb Vasc Biol, 1998, 18:1386 - 1392.
7Cermak J, Key NS, Bach RR, et al. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood, 1993,82:513 -520.
8Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med, 1997: 336:973 -979.
9Ridker PM, Buring JE, Shih J, et al. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation, 1998, 98:731 -733.
10Rost NS, Wolf PA, Kase CS, et al. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke, 2001,32:2575 -2579.
4Malarstig A,Lindahl B,Wallentin L,et al.Soluble CIM OL levels are regulated by the 3459A 》G polymorphism and predict myocardial infarction and the efficacy of antithrombotic treatment in non-ST elevation acute coronary syndrome[J].Arterioscler Thromb Vasc Bio1,2006,26(1):1667-1673.
5Libby P,Ridker PM,Maseri A.Inflammation and athleroselerosis[J].Circulation,2005,105(3):1135-1137.
